Direct Pulp Capping Agent on Human Pulp Tissue

NCT06435065 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Reversible Pulpitis

Interventions

DRUG: Biodentine
DRUG: Mineral Tri-Oxide Aggregate
DRUG: THERACAL LC
DRUG: TRISTRONTIUM ALUMINATE

Sponsor

DR SURINDER SACHDEVA